The trading price of Navidea Biopharmaceuticals Inc. (AMEX:NAVB) closed higher on Tuesday, April 19, closing at $0.99, 11.74% higher than its previous close. >> 5
Tag: NAVB stock
Stocks to Trade
Navidea Biopharmaceuticals, Inc. (NAVB) stock soared 25.58% in the pre-market trading session at the price of $1.11 following the regulatory approval of Lymphoaim in India.